QTX3544 in Patients With Advanced Solid Tumors With KRAS G12V Mutations
QTX3544 in Patients With Advanced Solid Tumors With KRAS G12V Mutations
Active, not recruiting · NCT06715124 · Registry updated 2026-03-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| QTX3544 in Patients With Advanced Solid Tumors With KRAS G12V Mutations | Advanced Solid Tumors | Active, not recruiting | Phase 1 | 2026-03-02 | NCT06715124 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Quanta Therapeutics | 3 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Duke Cancer Center | Durham | United States | 3 |
| Florida Cancer Specialists & Research Institute | Sarasota | United States | 3 |
| Huntsman Cancer Institute, University of Utah | Salt Lake City | United States | 45 |
| Sarah Cannon Research Institute | Nashville | United States | 119 |
| Sarah Cannon Research Institute | Denver | United States | 16 |
| South Texas Accelerated Research Therapeutics Mountain Region, LLC | West Valley City | United States | 1 |
| South Texas Accelerated Research Therapeutics, LLC Midwest | Grand Rapids | United States | 2 |
| South Texas Accelerated Research Therapeutics, LLC San Antonio | San Antonio | United States | 2 |
| The University of Texas MD Anderson Cancer Center | Houston | United States | 207 |
| Yale Cancer Center | New Haven | United States | 21 |